Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvanced Medical Solutions Group Regulatory News (AMS)

Share Price Information for Advanced Medical Solutions Group (AMS)

Share Price is delayed by 15 minutes
Get Live Data
221.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.50 (0.227%)
Market Cap: £480.08m
AMS Live PriceLast checked at - London Stock Exchange

Intraday Advanced Medical Solutions Group Share Chart

AGM Statement

20 May 2014 07:00

RNS Number : 5053H
Advanced Medical Solutions Grp PLC
20 May 2014
 



 

20 May 2014

 

Advanced Medical Solutions Group plc

("AMS")

 

Annual General Meeting

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS.L), the global medical technology company, will hold its Annual General Meeting ("AGM") at 11.00 today at the offices of Tavistock Communications, 131 Finsbury Pavement, London, EC2A 1NT.

 

Chris Meredith, AMS's Chief Executive Officer, will give a presentation at the AGM, the slides from which will be made available on the Company's website www.admedsol.com. No new material information will be provided.

 

In line with last year's practice, AMS will be providing an update on trading in late June.

 

- ends -

 

For further information, please contact:

 

Advanced Medical Solutions Group plc

Tel: +44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Mary Tavener, Group Finance Director

 

 

 

Tavistock Communications

Tel: +44 (0) 20 7920 3150

John West / Chris Munden / Andrew Dunn

 

 

 

Investec Bank plc

Tel: +44 (0) 20 7597 5970

Daniel Adams

 

 

About Advanced Medical Solutions Group plc - see www.admedsol.com 

 

Founded in 1991, AMS is a leader in the development and manufacture of innovative and technologically advanced products for the US$15 billion global wound care market. Through a mix of organic development and a number of acquisitions, AMS now has a wide range of products based on technologies that include alginates, silver alginates, foams, collagens, cyanoacrylate adhesives and sutures.

 

AMS manufactures wound care products for an extensive list of Original Equipment Manufacturer ("OEM") customers around the world, but the majority of the Group's revenues now come from its own brands - ActivHeal® wound care products in the UK to the NHS, LiquiBand® cyanoacrylate products primarily in the UK, Europe and the USA, and RESORBA® sutures and collagen wound care products primarily in Europe. AMS develops innovative products from its R&D pipeline which it commercialises globally, either directly or through partnerships with its OEM customers.

 

AMS's products are sold globally via a network of regional or multinational partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia.

 

With 450 employees operating under four distinct business units (Branded Direct, Branded Distributed, OEM and Bulk Materials) that match its multiple products and routes-to-market, AMS's products are manufactured from two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMSFAFIUFLSESI
Date   Source Headline
20th Apr 20262:33 pmRNSForm 8.3 - Advanced Medical Solutions Group plc
20th Apr 20261:47 pmRNSForm 8.3 - Advanced Medical Solutions Group PLC
20th Apr 20261:07 pmRNSForm 8 (OPD) - Advanced Medical Solutions Group
20th Apr 202612:23 pmEQSForm 8.3 - Advanced Medical Solutions Group plc
20th Apr 20267:45 amRNSDisclosure Table
20th Apr 20267:00 amRNSStatement re Possible Offer
8th Apr 20266:13 pmRNSHolding(s) in Company
31st Mar 20266:17 pmRNSTotal Voting Rights
18th Mar 20267:00 amRNSUnaudited Preliminary Results
10th Mar 20262:27 pmRNSHolding(s) in Company
6th Mar 20267:00 amRNSBlock listing Interim Review
2nd Mar 20269:00 amRNSTotal Voting Rights
30th Jan 20264:04 pmRNSTotal Voting Rights
28th Jan 20266:11 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSFull Year 2025 Trading Update
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
28th Nov 20252:31 pmRNSTotal Voting Rights
24th Nov 202511:46 amRNSHolding(s) in Company
10th Nov 202512:38 pmRNSHolding(s) in Company
31st Oct 20252:50 pmRNSTotal Voting Rights
27th Oct 20257:00 amRNS-RUpcoming Investor Conferences
16th Oct 20255:25 pmRNSHolding(s) in Company
16th Oct 20252:34 pmRNSHolding(s) in Company
8th Oct 20254:14 pmRNSDirector/PDMR Shareholding
1st Oct 20259:14 amRNSTotal Voting Rights
25th Sep 20256:25 pmRNSDirector/PDMR and PCA Shareholding
22nd Sep 20254:15 pmRNSHolding(s) in Company
17th Sep 20257:00 amRNSInterim Results
10th Sep 20257:00 amRNSApplication for Admission
9th Sep 20256:28 pmRNSBlock listing Interim Review
1st Sep 202512:39 pmRNSTotal Voting Rights
1st Sep 20257:00 amRNSNotice of Interim Results
31st Jul 20255:36 pmRNSTotal Voting Rights
15th Jul 20257:00 amRNSHalf Year Trading Update
1st Jul 202511:43 amRNSTotal Voting Rights
30th Jun 20251:29 pmRNSResults of Annual General Meeting
30th Jun 20257:00 amRNSAnnual General Meeting
23rd Jun 20257:00 amRNSDirectorate Change
3rd Jun 20254:34 pmRNSAnnual Report and Notice of Annual General Meeting
3rd Jun 20252:04 pmRNSHolding(s) in Company
2nd Jun 20251:31 pmRNSTotal Voting Rights
2nd Jun 20257:00 amRNSAppointment of Joint Corporate Broker
15th May 20256:25 pmRNSDirector/PDMR Shareholding
14th May 20253:02 pmRNSTiming of AGM and Change of Dividend Record Date
6th May 20255:40 pmRNSDirector/PDMR Shareholding
6th May 202511:26 amRNSForm 8.3 - Advanced Medical Solutions Group plc
2nd May 202511:06 amRNSForm 8.3 - Advanced Medical Solutions Group plc
1st May 202512:07 pmRNSForm 8.3 - Advanced Medical Solutions Group plc
30th Apr 20254:11 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.